Industry

SAN ANTONIO, Texas–(BUSINESS WIRE)–#CriticalCare–Turn Medical, a medical device company and the manufacturer of the Pronova-O2™ Automated Prone Therapy System, has received the Breakthrough Technology Award and a group purchasing agreement with Premier, Inc. Effective July 1, 2022, through February 28, 2025, the new agreement allows Premier members, at their discretion, to take advantage of special … [Read more…]

Veteran Digital Health and Sales Leader to Lead Transcarent’s Expansion into Self-Insured Employer Market, including Health Systems and Government Entities PALO ALTO, Calif.–(BUSINESS WIRE)–Transcarent, a new, different, and better health and care experience company for employees of self-insured employers and their families, today announced the appointment of Peter Bridges as its new Chief Commercial Officer. … [Read more…]

Funding will support community-based initiatives aiming to boost African American childhood development and improve educational achievement gaps MINNEAPOLIS–(BUSINESS WIRE)–UnitedHealthcare, a UnitedHealth Group (NYSE: UNH) company, awarded a $150,000 grant to the African American Babies Coalition and Projects (Wilder AABC) in support of its initiatives to educate the community, recruit child care professionals and develop programs … [Read more…]

CAMBRIDGE, Mass.–(BUSINESS WIRE)–Caraway Therapeutics today announced that the Company will be participating in the William Blair Biotech Focus Conference, taking place July 13, 2022, in New York City. Caraway’s Chief Executive Officer, Martin D. Williams, will participate in a fireside chat with Myles Minter, PhD, Biotech Equity Research Analyst at William Blair, to discuss recent … [Read more…]

  SOUTH SAN FRANCISCO, Calif.–(BUSINESS WIRE)–Asher Biotherapeutics, Inc. (Asher Bio), a biotechnology company developing precisely-targeted immunotherapies for cancer, chronic viral infections and autoimmune disorders, today announced the appointment of Bob Deresiewicz, M.D., to its Board of Directors. Dr. Deresiewicz is a recently retired partner, portfolio manager and global industry analyst with Wellington Management Company, LLP. … [Read more…]

BOSTON–(BUSINESS WIRE)–#medtech–Over 120 female senior medtech executives gathered on June 14 for MedExecWomen’s annual conference: “Into the Future: New Healthcare Partnerships to Drive Value.” MedExecWomen, co-founded in 2019 by Laurie Halloran, president & CEO of Halloran Consulting Group, and Maria Shepherd, president & founder of Medi-Vantage, empowers women in leadership roles in the medical device, … [Read more…]

IMM-BCP-01 neutralized BA.4/.5 and BA.2.12.1 subvariants in pseudovirus testing IMM-BCP-01 currently in Phase 1b clinical testing with topline data expected in 2H 2022 EXTON, Pa.–(BUSINESS WIRE)–Immunome, Inc. (Nasdaq: IMNM), a biopharmaceutical company that utilizes its human memory B cell platform to discover and develop first-in-class antibody therapeutics, today announced that their cocktail (IMM-BCP-01) retained activity … [Read more…]

NEW YORK–(BUSINESS WIRE)–Kallyope, Inc., a leading biotechnology company focused on identifying and developing therapeutics involving the gut-brain axis, today announced the promotion of Shirly Pinto, Ph.D., to Chief Scientific Officer and the appointments of Jiajun Liu, Ph.D., as Vice President and Head of Biometrics and Michael Crutchlow, M.D., as Vice President and Head of Translational … [Read more…]

BeiGene and InnoRNA will jointly research a number of mRNA-LNP programs, and BeiGene will hold exclusive global development and commercialization rights for the product candidates from the programs BeiGene will also gain a non-exclusive license to InnoRNA’s proprietary LNP Technology to support internal discovery efforts CAMBRIDGE, Mass. & BASEL, Switzerland & BEIJING–(BUSINESS WIRE)–$BGNE #BeiGene–BeiGene (NASDAQ: … [Read more…]

ETTLINGEN, Germany–(BUSINESS WIRE)–$BRKR #BRKR–Bruker Corporation (Nasdaq: BRKR) today has launched PhenoRisk PACS™ RuO, a research-use-only NMR test for molecular phenomics research on ‘Long COVID’ patients’ blood samples, using a multiplexed combination of biomarkers discovered at the Australian National Phenome Center (ANPC) at Murdoch University, under Director Jeremy Nicholson. The PhenoRisk PACS™ RuO test is promising … [Read more…]